NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-β peptide

Journal of Alzheimer's Disease

Volumn 20, Issue 1, 2010, Pages 57-66

  Nair, Nanditha G ^a   Perry, George ^b,c   Smith, Mark A ^c   Reddy, V Prakash ^a  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^b University of San Antonio   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; amyloid peptide; aspartic acid; Fenton reaction; glutamic acid; histidine; metal ion chelation; NMR titrations; oxidative stress; tyrosine

Indexed keywords

AMYLOID BETA PROTEIN; ASPARTIC ACID; COPPER; FERROUS GLUCONATE; GLUTAMIC ACID; HISTIDINE; IRON; METAL ION; ZINC;

ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; METAL BINDING; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY; TITRIMETRY;

EID: 77954482455     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1346     Document Type: Article

References (31)

1. Ryu J, Girigoswami K, Ha C, Ku SH, Park CB (2008) Influence of Multiple Metal Ions on beta-Amyloid Aggregation and Dissociation on a Solid Surface. Biochemistry 47, 5328-5335.
2. Syme CD, Viles JH (2006) Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Ab) of Alzheimer's disease. Biochim Biophys Acta 1764, 246-256.
3. Ha C, Ryu J, Park CB (2007) Metal ions differentially influence the aggregation and deposition of Alzheimer's betaamyloid on a solid template. Biochemistry 46, 6118-6125.
4. Bishop GM, Robinson SR (2004) The amyloid paradox: Amyloid-beta - metal complexes can be neurotoxic and neuroprotective. Brain Pathol 14, 448-452.
5. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta 1-42. J Neurochem 75, 1219-1233.
6. Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI (2000) Alzheimer's disease, beta -amyloid protein and zinc. J Nutr 130, 1488S-1492S.
7. Zhu X, Perry G, Smith MA (2008) Two hits and you're out? A novel mechanistic hypothesis of Alzheimer disease. Adv Behav Biol 57, 191-204.
8. Barnham KJ, Curtain CC, Bush AI (2007) Free radicals, metal ions, and Aβ aggregation and neurotoxicity. Protein Rev 6, 31-47.
9. Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T (2007) Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry 46, 12737-12743.
10. Reddy VP, Zhu X, Perry G, Smith MA(2009) Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 16, 763-774.
11. Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling K-Q, Huang X, Moir RD, Wang D, Sayre LM, Smith MA, Chen SG, Bush AI (2004) Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 43, 560-568.
12. Cuajungco MP, Faget KY (2003) Zinc takes the center stage: its paradoxical role in Alzheimer's disease. Brain Res Rev 41, 44-56.
13. Danielsson J, Pierattelli R, Banci L, Graeslund A (2007) High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. FEBS J 274, 46-59.
14. Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I (2008) Zinc-amyloid beta interactions on a millisecond timescale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc 130, 1376-1383.
15. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci 29, 4004-4015.
16. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432.
17. Koppenal C, Finefrock AE, Bush AI, Doraiswamy PM (2004) Copper, iron and zinc as therapeutic targets in Alzheimer's disease. Res Pract Alzheimers Dis 9, 250-255.
18. Aziz EF, Eberhardt W, Eisebitt S (2008) Effect of cysteine vs. histidine on the electronic structure of Zn2+ upon complex formation. Z Phys Chem 222, 727-738.
19. Gaggelli E, Janicka-Klos A, Jankowska E, Kozlowski H, Migliorini C, Molteni E, Valensin D, Valensin G, Wieczerzak E (2008) NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment. J Phys Chem B 112, 100-109.
20. Zirah S, Kozin SA, Mazur AK, Blond A, Cheminant M, Segalas-Milazzo I, Debey P, Rebuffat S (2006) Structural changes of region 1-16 of the Alzheimer disease amyloid betapeptide upon zinc binding and in vitro aging. J Biol Chem 281, 2151-2161.
21. Mekmouche Y, Coppel Y, Hochgrafe K, Guilloreau L, Talmard C, Mazarguil H, Faller P (2005) Characterization of the ZnII binding to the peptide amyloid-beta 1-16 linked to Alzheimer's disease. ChemBioChem 6, 1663-1671.
22. Minicozzi V, Stellato F, Comai M, Dalla Serra M, Potrich C, Meyer-Klaucke W, Morante S (2008) Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides. J Biol Chem 283, 10784-10792.
23. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ, Masters CL, Bush AI, Barnham KJ (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membranepenetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276, 20466-20473.
24. Syme CD, Nadal RC, Rigby SEJ, Viles JH (2004) Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. J Biol Chem 279, 18169-18177.
25. DrewSC, Masters CL, Barnham KJ (2009) Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide - relevance to n-terminally truncated forms. J Am Chem Soc 131, 8760-8761.
26. Hou L, Zagorski MG (2006) NMR reveals anomalous copper( ii) binding to the amyloid abeta peptide of Alzheimer's disease. J Am Chem Soc 128, 9260-9261.
27. Sarell CJ, Syme CD, Rigby SEJ, Viles JH (2009) Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geome try are independent of Aβ oligomeric form. Biochemistry 48, 4388-4402.
28. Streltsov VA, Titmuss SJ, Epa VC, Barnham KJ, Masters CL, Varghese JN (2008) The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Biophys J 95, 3447-3456.
29. Ma Q-F, Hu J, Wu W-H, Liu H-D, Du J-T, Fu Y, Wu Y-W, Lei P, Zhao Y-F, Li Y-M (2006) Characterization of copper binding to the peptide amyloid-beta (1-16) associated with Alzheimer's disease. Biopolymers 83, 20-31.
30. Connors KA (1987) Binding Constants: The Measurements of Molecular Complex Stability, Wiley, New York.
31. Deschamps P, Kulkarni PP, Sarkar B (2004) X-ray structure of physiological copper(II)-Bis(L-histidinato) complex. Inorg Chem 43, 3338-3340.